NASDAQ · NICE
NICE financials
$106.81−2.09%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.95B | $2.74B | $2.38B | $2.18B | $1.92B | $1.65B | $1.57B | $1.44B | $1.33B | $1.02B |
| Gross profit | $1.96B | $1.83B | $1.61B | $1.50B | $1.30B | $1.09B | $1.04B | $947.7M | $863.5M | $677.8M |
| Gross margin | 66.4% | 66.7% | 67.7% | 68.7% | 67.5% | 65.9% | 66.2% | 65.6% | 64.8% | 66.7% |
| Operating income | $645.8M | $546.0M | $435.2M | $335.2M | $263.9M | $242.0M | $238.7M | $197.6M | $150.1M | $134.2M |
| Net income | $612.1M | $442.6M | $338.3M | $265.9M | $199.2M | $196.3M | $185.9M | $159.3M | $143.3M | $116.9M |
| Net margin | 20.8% | 16.2% | 14.2% | 12.2% | 10.4% | 11.9% | 11.8% | 11.0% | 10.8% | 11.5% |
| Diluted EPS | $9.67 | $6.76 | $5.11 | $4.00 | $2.98 | $2.98 | $2.88 | $2.52 | $2.31 | $1.92 |
| EBITDA | $844.8M | $751.0M | $602.6M | $511.7M | $448.0M | $424.1M | $411.9M | $354.8M | $306.4M | $212.0M |
| Operating cash flow | $716.5M | $832.6M | $561.4M | $479.7M | $461.8M | $480.3M | $374.2M | $396.6M | $394.7M | $228.2M |
| Free cash flow | $697.6M | $797.7M | $532.2M | $447.8M | $437.0M | $456.1M | $346.9M | $365.2M | $354.8M | $200.9M |
| Diluted shares | 63.3M | 65.5M | 66.3M | 66.5M | 66.9M | 66.0M | 64.7M | 63.3M | 62.1M | 61.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $379.4M | $481.7M | $511.8M | $529.6M | $378.7M | $442.3M |
| Short-term investments | $38.0M | $1.14B | $896.0M | $1.04B | $1.05B | $1.02B |
| Total debt | $0.00 | $458.8M | $666.3M | $664.7M | $825.2M | $681.2M |
| Total assets | $5.11B | $5.30B | $5.12B | $4.85B | $4.71B | $4.23B |
| Total liabilities | $1.23B | $1.69B | $1.76B | $1.80B | $1.87B | $1.64B |
| Shareholders' equity | $3.88B | $3.60B | $3.35B | $3.06B | $2.84B | $2.59B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology